|New Protease Inhibitor
Aug 18, 2000
Hello doc. Are you aware of a new protease inhibitor from Bristol Myers called BMS-232632? It's supposedly more potent than any known protease inhibitor, but I don't have any information on the current phase it's in...
| Response from Dr. Pavia
BMS-232632 is a new protease inhibitor that is being developed by Bristol Myers Squibb. Luckily, it is about due to get a real name. The studies presented so far have demonstrated that it has a long half life and probably can be used as a once a day drug. In addition, it is active against many strains of HIV with resistance to one protease inhibitor. There are fewer data on highly multi-resistant virus. The drug is entering phase 2-3 trials around the country. You can keep an eye out for trials that are enrolling by calling 1-800-trials-A, or looking for trial information on this site, HIVinsite (www.hivinsite.ucsf.edu), and the AIDS clinical trial information service (http://www.actis.org/)
Hope this helps
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.